Download vapreotide acetate CAS:103222-11-3 release formulation of Sanvar

Vapreotide Acetate Human Growth Hormone Peptide Release Formulation Of Sanvar
Brand Name
QA
Model Number
[email protected]
Certification
ISO9001, Kosher, COA
Place of Origin
China
Minimum Order
Quantity
1vial
Price
Negotiated
Payment Terms
T/T, Western Union, MoneyGram,Bitcoin
Supply Ability
Mass stock
Delivery Time
within 12h after receiving your payment
Packaging Details
Discreet packing
Molecular Formula:
C57H70N12O9S2
Molecular Weight:
1131.40
Purity
98.0%
Products Detailed
vapreotide acetate CAS:103222-11-3 release formulation of Sanvar
Delivery
Sent out within 12 hours after payment confirmed
Packaging
Disguised package or as required
Discount
Larger quantity of each item
Quick Detail:
vapreotide acetate-Product Name:vapreotide acetate
vapreotide acetate-Sequence: D-Phe-[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2
vapreotide acetate-Alias:Sanvar,RC-160;VAPREOTIDE;D-PHE-CYS-TYR-D-TRP-LYS-VAL-CYS-TRP-NH2;
Octastatin;
FCYWKVCW-NH2;D-Phe-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Trp-NH2;
vapreotide acetate-Cas No.: 103222-11-3
vapreotide acetate-Molecular Formula: C57H70N12O9S2
vapreotide acetate-Molecular Weight: 1131.40
vapreotide acetate-Purity (HPLC): 98.0%
vapreotide acetate-Appearance: White powder
vapreotide acetate-Single Impurity(HPLC): 1.0%
vapreotide acetate-Amino Acid Composition: 10% of theoretical
vapreotide acetate-Peptide Content(N%): 80%(by %N)
vapreotide acetate-Water Content(Karl Fischer): 6.0%
vapreotide acetate-Acetate Content(HPIC): 15.0%
vapreotide acetate-Mass Balance: 95.0~105.0%
vapreotide acetate-Grade : Pharmaceutical Grade
vapreotide acetate-Storage: Closed, below 2 ~ 8ºC preservation
vapreotide acetate-Manufacturer :SUPER STEROIDS
vapreotide acetate-Delivery time : within 18 hours upon receipt of payment
vapreotide acetate-Delivery: EMS, DHL, TNT, FedEx, UPS
vapreotide acetate-Usage : The drug can be used for treatment of early acute esophageal variceal bleeding
(EVB) and endoscopic interventional therapy before hemostasis, can also be bleeding within 5 d lens for the
treatment and prevention of recurrence after endoscopic.vapreotide acetate will be the only approved
treatment for esophageal variceal bleeding in the United States.
2.Description:
Variceal bleeding is a life-threatening complication of portal hypertension. The recommended treatment
includes the early administration of a vasoactive drug. Vapreotide is a somatostatin analogue with a different
receptor affinity to octreotide. It decreases portal pressure and blood flow of collateral circulation in rats with
cirrhosis. The pivotal study of early administration of vapreotide in patients with cirrhosis and variceal bleeding
has shown a significant improvement in bleeding control and, in the subset of patients with significant
bleeding, a significant reduction in mortality. In addition, a meta-analysis of four randomized studies has
shown a significant improvement in bleeding control. Vapreotide administrated via the intravenous route is
simple to use, with practically no contraindications and few, usually minor, side effects.
3.Application:
The immediate release formulation of Sanvar, a somatostatin analogue, is used in the treatment of acute
esophageal variceal bleeding (EVB).
Sanvar is used prior to endoscopic intervention to control haemorrhage and prevent re-bleeding during the
critical five days following the onset of bleeding. EVB is a life threatening condition and the mortality rate is
high (about 15% to 25%) in the first six weeks following the haemorrhage. EVB is the cause of about 70% of
gastro-intestinal bleeding in patients suffering from liver cirrhosis.
Sanvar (vapreotide acetate) is a synthetic octapeptide analogue of the naturally-occurring somatostatin
hormone. It has similar pharmacological properties to native somatostatin, but exhibits a longer duration of
action. It is the only somatostatin analogue to have demonstrated statistically significant benefits in the early
treatment of EVB in association with endoscopic therapy, in a placebo-controlled clinical study (Calès et al.
New England Journal of Medicine, 2001). Control of bleeding with survival at five days was achieved more
often with Sanvar (p=0.021) than with placebo. Additional Phase III trials have been completed in Europe in
this indication. Sanvar can be stored at room temperature, an advantage over other products requiring
refrigeration, allowing immediate administration, a key benefit in a life-threatening situation. The product has
been granted orphan drug status in the U.S., where there is currently no FDA approved treatment for this
indication.
Related products:
HGH 176-191 2mg/vial 10vials/kit
GHRP-2 5mg/vial 10vials/kit
GHRP-2 10mg/vial 10vials/kit
GHRP-6 5mg/vial 10vials/kit
GHRP-6 10mg/vial 10vials/kit
MGF 2mg/vial 10vials/kit
PEG MGF 2mg/vial 10vials/kit
CJC-1295 with DAC 2mg/vial
10vials/kit
CJC-1295 without DAC 2mg/vial
10vials/kit
PT-141 10mg/vial 10vials/kit
Melanotan-1 10mg/vial 10vials/kit
Melanotan-2 10mg/vial 10vials/kit
Ipamorelin 2mg/vial 10vials/kit
Hexarelin 2mg/vial 10vials/kit
Sermorelin 2mg/vial 10vials/kit
Oxytocin 2mg/vial 10vials/kit
TB500 2mg/vial 10vials/kit
Pentadecapeptide BPC 157 2mg/vial
10vials/kit
Triptorelin 2mg/vial 10vials/kit
Gonadorelin 2mg/vial 10vials/kit
Gonadorelin 10mg/vial 10vials/kit
Tesamorelin 2mg/vial 10vials/kit
DSIP 2mg/vial 10vials/kit
Selank 5mg/vial 10vials/kit
AICAR CAS:221231-10-3
Adipotide 2mg/vial 10vials/kit
AOD9604 2mg/vial 10vials/kit
BPC 157 5mg/vial 10vials/kit
Epithalon 20mg/vial 10vials/kit
Epithalon 50mg /vial 10vials/kit
Follistatin-315 1mg/vial 10vials/kti
Follistatin-344 1mg/vial 10vials/kit
Follistatin-314 1mg/vial 10vials/kti
Thyrotropin TRH 2mg/vial 10vials/kit
Medical Peptides
Aviptadil Acetate CAS:40077-57-4
Alarelin Acetate CAS: 79561-22-1
Antide Acetate CAS: 112568-12-4
Angiotensin Acetate CAS: 58-49-1
CJC-1295 Acetate
Eledoisin Acetate CAS: 69-25-0
Argpressin Acetate CAS: 113-79-1
PT141 Acetate CAS: 32780-32-8
Bivalirudin Trifluoroacetate CAS:
128270-60-0
Deslorelin Acetate CAS: 57773-65-5
Desmopressin Acetate CAS: 1678998-3
Elcatonin Acetate CAS: 60731-46-6
Fertirelin Acetate CAS: 38234-21-8
Enfuvirtide Acetate (T-20)
CAS:159519-65-0
Exenatide Acetate (Exendin-4)
Eptifibatide CAS: 148031-34-9
CAS: 141758-74-9
Glucagon(1-29)(Human) CAS:16941- GLP-1 (7-37) Acetate CAS: 10661232-5
94-6
Gonadorelin Acetate CAS: 71447-49GHRP-2 Acetate CAS: 158861-67-7
9
GHRP-6 Acetate CAS: 87616-84-0
Hexarelin CAS:140703-51-1
Leuprolide CAS:53714-56-0
Lysipressin Acetate CAS:50-57-7
Triptorelin Acetate CAS: 57773-63-4
Nesiritide Acetate (BNP-32)
CAS:114471-18-0
Octreotide Acetate CAS: 83150-76-9
GRF(human)Acetate CAS:83930-13-6
Oxytocin Acetate CAS: 50-56-6
Ornipressin Acetate CAS:3397-23-7
Pramlintide Acetate CAS: 196078-30- Splenopentin Acetate CAS:1051845
37-0
Secretin Acetate CAS:17034-35-4
Sermorelin Acetate CAS:86168-78-7
Somatostatin Acetate CAS: 3891634-6
Teriparatide Acetate CAS:52232-67-4
Tetracosactide Acetate CAS:1696016-0
Vapreotide Acetate CAS:103222-11-3
Terlipressin Acetate CAS:14636-12-5 Thymosin a1 Acetate CAS:62304-98-7
Thymosin b4 Acetate CAS:77591-33Ziconotide Acetate CAS:107452-89-1
4
cosmitic peptides
Acetyl Hexapeptide-3 CAS: 61620422-9
cetyl Tetrapeptide-5 CAS:820959-17-9
GHK/GHK-Cu copper peiptde CAS
NO:49557-75-7
Cosmitic peptides Argireline CAS:
616204-22-9
Palmitoyl Pentapeptide CAS:21404700-4
Peptidic APIs
CETRORELIX CAS:145672-81-7
Abarelix CAS:183552-38-7
Alarelin Acetate CAS: 79561-22-1
Atosiban CAS:90779-69-4
Icatibant CAS:130308-48-4
Antide CAS: 112568-12-4
Octreotide Acetate CAS: 83150-76-9
Bivalirudin CAS:128270-60-0
Exenatide acetate CAS:141732-76-5
Carbetocin Acetate CAS:37025-55-1
Caspofungin Acetate CAS :17946317-3
Leuprorelin acetate CAS:74381-53-6
Pramlintide acetate CAS: 196078-30- Teriparatide Acetate CAS : 52232-675
4
Angiotensin Acetate Cas:58-49-1
Deslorelin Acetate CAS 57773-65-6
DEGARELIX CAS:214766-78-6
Enfuvirtide Acetate Cas: 159519-65-0
Fertirelin Acetate Cas: 38234-21-8
Goserelin CAS:65807-02-5
Vasopressin CAS.:50-57-7
Calcitonin CAS:9007-12-9
Lysipressin Acetate Cas: 50-57-7
Lanreotide CAS:108736-35-2
Liraglutide CAS:204656-20-2
Linaclotide CAS:851199-59-2
Nafarelin CAS:76932-56-4
Protirelin CAS:24305-27-9
Desmopressin Acetate CAS 1678998-3
GLP-1 (7-37) Acetate Cas : 10661294-6
Somatostatin Acetate Cas: 38916-34Oxtocin CAS:50-56-6
6
Terlipressin CAS:14636-12-5
Sincalide CAS:25126-32-3
Thymosin a 1 Acetate CAS: 6230498-7
Thymosin b4 CAS:77591-33-4
Thymopentin CAS:69558-55-0
Aviptadil Acetate Cas:40077-57-4
Eptifibatide CAS: 148031-34-9
Elcatonin CAS 60731-46-6
Glucagon(1-29)(Human) Cas: 16941- GLP-1(7-36), IRP peptide CAS:
32-5
107444-51-9
Histrelin CAS:76712-82-8
Guangzhou Quanao Chemical Co.,Ltd
BUsiness Type:
Manufacturer Exporter
Main Market:
North America South America Western Europe Eastern Europe Eastern Asia Southeast Asia Middle East Africa Oceania Worldwide
Brands:
quanao
Employee Number:
200~300People
Total Annual Sales Volume:
90% - 100%
Year Established:
2001
Contact this Supplier:
Telphone:
86--17701959745
Fax:
86-020-17701959745
Email:
[email protected]
Address:
Room 1102 1 Unit 16 building South time NANSHA district ,Guangzhou,Guangdong ,China.